124 related articles for article (PubMed ID: 38453845)
41. [DIAGNOSTIC MARKERS FOR CHRONIC PANCREATITIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH DIFFERENT PHENOTYPE].
Zhuravlyova LV; Shekhovtsova Y A
Eksp Klin Gastroenterol; 2015; (6):47-52. PubMed ID: 26817104
[TBL] [Abstract][Full Text] [Related]
42. Potential for Screening for Pancreatic Exocrine Insufficiency Using the Fecal Elastase-1 Test.
Domínguez-Muñoz JE; D Hardt P; Lerch MM; Löhr MJ
Dig Dis Sci; 2017 May; 62(5):1119-1130. PubMed ID: 28315028
[TBL] [Abstract][Full Text] [Related]
43. Pancreatic elastase 1 in stool: variations within one stool passage and individual changes from day to day.
Hamwi A; Veitl M; Maenner G; Vogelsang H; Szekeres T
Wien Klin Wochenschr; 2000 Jan; 112(1):32-5. PubMed ID: 10689738
[TBL] [Abstract][Full Text] [Related]
44. Comparison of the elastolytic effects of human leukocyte elastase and porcine pancreatic elastase.
Senior RM; Bielefeld DR; Starcher BC
Adv Exp Med Biol; 1977; 79():249-61. PubMed ID: 868639
[TBL] [Abstract][Full Text] [Related]
45. [Changes in the activity of elastase and its inhibitors in the aorta tissue and blood serum of rats with streptozocin-induced diabetes].
Borysiuk MV
Fiziol Zh (1994); 2002; 48(4):47-52. PubMed ID: 12226926
[TBL] [Abstract][Full Text] [Related]
46. Serum immunoreactive elastase: is it useful for the diagnosis of pancreatic cancer?
Gullo L; Pezzilli R; Ventrucci M; Lesi C; Zoni L; D'Ambrosi A; Alvisi V
Pancreas; 1989; 4(3):335-8. PubMed ID: 2734276
[TBL] [Abstract][Full Text] [Related]
47. Association of faecal elastase 1 with non-fasting triglycerides in type 2 diabetes.
Rathmann W; Haastert B; Oscarsson J; Berglind N; Lindkvist B; Wareham NJ
Pancreatology; 2016; 16(4):563-9. PubMed ID: 27086060
[TBL] [Abstract][Full Text] [Related]
48. Fecal pancreatic elastase-1 and erythrocyte magnesium levels in diabetes type 1 and type 2.
Čabarkapa V; Djerić M; Mitrović M; Kojić-Damjanov S; Isakov I; Vuković B; Popović D
Magnes Res; 2018 Feb; 31(1):1-10. PubMed ID: 30106003
[TBL] [Abstract][Full Text] [Related]
49. [Elastase].
Hayakawa T; Naruse S; Kitagawa M; Kondo T
Nihon Rinsho; 1995 May; 53(5):1192-7. PubMed ID: 7602777
[TBL] [Abstract][Full Text] [Related]
50. Pancreatic lipomatosis is a structural marker in nondiabetic children with mutations in carboxyl-ester lipase.
Raeder H; Haldorsen IS; Ersland L; Grüner R; Taxt T; Søvik O; Molven A; Njølstad PR
Diabetes; 2007 Feb; 56(2):444-9. PubMed ID: 17259390
[TBL] [Abstract][Full Text] [Related]
51. [Elastolytic system of the pancreas in modelling diabetes mellitus].
Borysiuk MV; Dosenko VIe; Byts' IuV
Fiziol Zh (1994); 2002; 48(5):17-21. PubMed ID: 12449609
[TBL] [Abstract][Full Text] [Related]
52. An immunoassay for canine pancreatic elastase 1 as an indicator for exocrine pancreatic insufficiency in dogs.
Spillmann T; Wittker A; Teigelkamp S; Eim C; Burkhardt E; Eigenbrodt E; Sziegoleit A
J Vet Diagn Invest; 2001 Nov; 13(6):468-74. PubMed ID: 11724136
[TBL] [Abstract][Full Text] [Related]
53. Presence of human immunoglobulin G anti serum pancreatic elastase 1 autoantibodies and their influence on elastase 1 radioimmunoassay.
Asada H; Shibata K; Uchida K; Yamauchi A; Kono M; Takeyama Y; Ohyanagi H; Saitoh Y
Biochim Biophys Acta; 1991 Oct; 1080(1):34-9. PubMed ID: 1932080
[TBL] [Abstract][Full Text] [Related]
54. Radioimmunoassay of human pancreatic elastase 1. In vitro interaction of human pancreatic elastase 1 with serum protease inhibitors.
Murata A; Ogawa M; Fujimoto K; Kitahara T; Matsuda Y; Kosaki G
Enzyme; 1983; 30(1):29-37. PubMed ID: 6191979
[TBL] [Abstract][Full Text] [Related]
55. Does pancreatic elastase-1 in stools predict steatorrhea in type 1 diabetes?
Cavalot F; Bonomo K; Fiora E; Bacillo E; Salacone P; Chirio M; Gaia E; Trovati M
Diabetes Care; 2006 Mar; 29(3):719-21. PubMed ID: 16505538
[No Abstract] [Full Text] [Related]
56. Alterations in serum pancreatic elastase 1 content in acute and chronic pancreatitis: comparison with alpha-amylase activity.
Umeki S; Satoh T; Ueda S
J Lab Clin Med; 1985 Nov; 106(5):578-82. PubMed ID: 3877132
[TBL] [Abstract][Full Text] [Related]
57. Limitations of faecal elastase-1 and chymotrypsin as tests of exocrine pancreatic disease in adults.
Brydon WG; Kingstone K; Ghosh S
Ann Clin Biochem; 2004 Jan; 41(Pt 1):78-81. PubMed ID: 14713391
[TBL] [Abstract][Full Text] [Related]
58. Serum immunoreactive elastase in diagnosis of pancreatic diseases. A sensitive marker for pancreatic cancer.
Hamano H; Hayakawa T; Kondo T
Dig Dis Sci; 1987 Jan; 32(1):50-6. PubMed ID: 2431845
[TBL] [Abstract][Full Text] [Related]
59. MRI and MRCP findings of the pancreas in patients with diabetes mellitus: compared analysis with pancreatic exocrine function determined by fecal elastase 1.
Bilgin M; Balci NC; Momtahen AJ; Bilgin Y; Klör HU; Rau WS
J Clin Gastroenterol; 2009 Feb; 43(2):165-70. PubMed ID: 18797409
[TBL] [Abstract][Full Text] [Related]
60. Which factors determine exocrine pancreatic dysfunction in diabetes mellitus?
Altay M
World J Gastroenterol; 2019 Jun; 25(22):2699-2705. PubMed ID: 31235993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
